Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-14 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
A | Ordinary Shares | A | 3193 | $9.57 - $9.57 | $30,557 |
2024-11-11 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
S | Ordinary Shares | D | 4000 | $9.00 - $9.00 | $36,000 |
2024-08-20 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
F | Ordinary Shares | D | 15997 | $8.22 - $8.22 | $131,495 |
2024-08-20 | Theravance Biopharma, Inc. | Sawaf Aziz
(SVP & CHIEF FINANCIAL OFFICER) |
F | Ordinary Shares | D | 8635 | $8.22 - $8.22 | $70,979 |
2024-08-20 | Theravance Biopharma, Inc. | Miller Aine
(SVP, DEV & HEAD OF IRE OFFICE) |
F | Ordinary Shares | D | 5201 | $8.22 - $8.22 | $42,752 |
2024-08-20 | Theravance Biopharma, Inc. | Grimaud Brett A.
(SVP, GEN COUNSEL AND SECRETARY) |
F | Ordinary Shares | D | 9268 | $8.22 - $8.22 | $76,182 |
2024-08-20 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
F | Ordinary Shares | D | 9222 | $8.22 - $8.22 | $75,804 |
2024-08-07 | Theravance Biopharma, Inc. | Winningham Rick E
(CHIEF EXECUTIVE OFFICER) |
A | Ordinary Shares | A | 3252 | $7.83 - $7.83 | $25,463 |
2024-08-07 | Theravance Biopharma, Inc. | Samaha Eli
(AtLeastTenPercentOwner) |
P | COM | A | 999800 | $7.80 - $7.80 | $7,798,440 |
2024-07-10 | Theravance Biopharma, Inc. | Farnum Rhonda
(SVP, COMM & MEDICAL AFFAIRS) |
S | Ordinary Shares | D | 4000 | $9.00 - $9.00 | $36,000 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |